1. Yokoyama, A. et al. Age-related remodelling of oesophageal epithelia by mutated cancer drivers. Nature 565, 312-317 (2019).
2. Martincorena, I. et al. Somatic mutant clones colonize the human esophagus with age. Science 362, 911-917 (2018).
3. de Beco, S., Ziosi, M. & Johnston, L.A. New frontiers in cell competition. Dev. Dyn. 241, 831-841 (2012).
4. Bowling, S., Lawlor, K. & Rodriguez, T.A. Cell competition: the winners and losers of fitness selection. Development 146 (2019).
5. Vishwakarma, M. & Piddini, E. Outcompeting cancer. Nat. Rev. Cancer 20, 187-198 (2020).
6. Baker, N.E. Emerging mechanisms of cell competition. Nat. Rev. Genet. 21, 683-697 (2020).
7. Kon, S. Physiological and pathological relevance of cell competition in fly to mammals. Dev. Growth Differ. 60, 14-20 (2018).
8. Claveria, C. & Torres, M. Cell Competition: Mechanisms and Physiological Roles. Annu. Rev. Cell. Dev. Biol. 32, 411-439 (2016).
9. Merino, M.M., Levayer, R. & Moreno, E. Survival of the Fittest: Essential Roles of Cell Competition in Development, Aging, and Cancer. Trends Cell Biol. 26, 776-788 (2016).
10. Marques-Reis, M. & Moreno, E. Role of cell competition in ageing. Dev. Biol. 476, 79-87 (2021).
11. Amoyel, M. & Bach, E.A. Cell competition: how to eliminate your neighbours. Development 141, 988-1000 (2014).
12. Di Gregorio, A., Bowling, S. & Rodriguez, T.A. Cell Competition and Its Role in the Regulation of Cell Fitness from Development to Cancer. Dev. Cell 38, 621-634 (2016).
13. Morata, G. & Ripoll, P. Minutes: mutants of drosophila autonomously affecting cell division rate. Dev. Biol. 42, 211-221 (1975).
14. Levayer, R. & Moreno, E. Mechanisms of cell competition: themes and variations. J. Cell Biol. 200, 689-698 (2013).
15. Parker, T.M. et al. Cell competition in intratumoral and tumor microenvironment interactions. EMBO J. 40, e107271 (2021).
16. Nagata, R. & Igaki, T. Cell competition: Emerging mechanisms to eliminate neighbors. Dev. Growth Differ. 60, 522-530 (2018).
17. Kon, S. & Fujita, Y. Cell competition-induced apical elimination of transformed cells, EDAC, orchestrates the cellular homeostasis. Dev. Biol. 476, 112-116 (2021).
18. Maruyama, T. & Fujita, Y. Cell competition in mammals - novel homeostatic machinery for embryonic development and cancer prevention. Curr. Opin. Cell Biol. 48, 106-112 (2017).
19. Nichols, J., Lima, A. & Rodriguez, T.A. Cell competition and the regulative nature of early mammalian development. Cell Stem Cell 29, 1018-1030 (2022).
20. Madan, E., Gogna, R. & Moreno, E. Cell competition in development: information from flies and vertebrates. Curr. Opin. Cell Biol. 55, 150-157 (2018).
21. Kon, S. et al. Cell competition with normal epithelial cells promotes apical extrusion of transformed cells through metabolic changes. Nat. Cell Biol. 19, 530-541 (2017).
22. Sasaki, A. et al. Obesity Suppresses Cell-Competition-Mediated Apical Elimination of RasV12-Transformed Cells from Epithelial Tissues. Cell Rep 23, 974-982 (2018).
23. Sato, N. et al. The COX-2/PGE2 pathway suppresses apical elimination of RasV12-transformed cells from epithelia. Commun Biol 3, 132 (2020).
24. Mori, Y. et al. Extracellular ATP facilitates cell extrusion from epithelial layers mediated by cell competition or apoptosis. Curr. Biol. 32, 2144-2159 e2145 (2022).
25. Hata, M. et al. GPR30-Expressing Gastric Chief Cells Do Not Dedifferentiate But Are Eliminated via PDK-Dependent Cell Competition During Development of Metaplasia. Gastroenterology 158, 1650-1666.e1615 (2020).
26. Fearon, E.R. & Vogelstein, B. A Genetic Model for Colorectal Tumorigenesis. Cell 61, 759-767 (1990).
27. Hanahan, D. & Weinberg, R.A. The hallmarks of cancer. Cell 100, 57-70 (2000).
28. Vogelstein, B. & Kinzler, K.W. The multistep nature of cancer. Trends Genet. 9, 138-141 (1993).
29. Schmitt, M. & Greten, F.R. The inflammatory pathogenesis of colorectal cancer. Nat. Rev. Immunol. 21, 653-667 (2021).
30. Jen, J. et al. Molecular determinants of dysplasia in colorectal lesions. Cancer Res. 54, 5523-5526 (1994).
31. Powell, S.M. et al. APC mutations occur early during colorectal tumorigenesis. Nature 359, 235-237 (1992).
32. Moser, A.R., Pitot, H.C. & Dove, W.F. A Dominant Mutation That Predisposes to Multiple Intestinal Neoplasia in the Mouse. Science 247, 322-324 (1990).
33. el Marjou, F. et al. Tissue-specific and inducible Cre-mediated recombination in the gut epithelium. Genesis 39, 186-193 (2004).
34. Shoemaker, A.R., Gould, K.A., Luongo, C., Moser, A.R. & Dove, W.F. Studies of neoplasia in the Min mouse. Biochim Biophys Acta 1332, F25-48 (1997).
35. Lauren, P. THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. Acta Pathol Microbiol Scand 64, 31-49 (1965).
36. Mueller, J. et al. EXPRESSION OF bcl-2 AND p53 INDE NOVO AND EX-ADENOMA COLON CARCINOMA: A COMPARATIVE IMMUNOHISTOCHEMICAL STUDY. The Journal of Pathology 180, 259-265 (1996).
37. Barth, A.I., Pollack, A.L., Altschuler, Y., Mostov, K.E. & Nelson, W.J. NH2-terminal deletion of beta-catenin results in stable colocalization of mutant beta-catenin with adenomatous polyposis coli protein and altered MDCK cell adhesion. J. Cell Biol. 136, 693-706 (1997).
38. Akieda, Y. et al. Cell competition corrects noisy Wnt morphogen gradients to achieve robust patterning in the zebrafish embryo. Nat Commun 10, 4710 (2019).
39. Brown, S. et al. Correction of aberrant growth preserves tissue homeostasis. Nature 548, 334-337 (2017).
40. Egeblad, M. & Werb, Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2, 161-174 (2002).
41. Cathcart, J., Pulkoski-Gross, A. & Cao, J. Targeting Matrix Metalloproteinases in Cancer: Bringing New Life to Old Ideas. Genes Dis 2, 26-34 (2015).
42. Marchenko, G.N., Marchenko, N.D. & Strongin, A.Y. The structure and regulation of the human and mouse matrix metalloproteinase-21 gene and protein. Biochem. J. 372, 503-515 (2003).
43. Ahokas, K. et al. Matrix metalloproteinase-21, the human orthologue for XMMP, is expressed during fetal development and in cancer. Gene 301, 31-41 (2002).
44. Yuan, Z.Z., Fan, L.L., Jiang, Z.C., Yang, Y.F. & Tan, Z.P. A Novel Nonsense MMP21 Variant Causes Dextrocardia and Congenital Heart Disease in a Han Chinese Patient. Front Cardiovasc Med 7, 582350 (2020).
45. Guimier, A. et al. MMP21 is mutated in human heterotaxy and is required for normal left-right asymmetry in vertebrates. Nat. Genet. 47, 1260-1263 (2015).
46. Akawi, N. et al. Discovery of four recessive developmental disorders using probabilistic genotype and phenotype matching among 4,125 families. Nat. Genet. 47, 1363-1369 (2015).
47. Ahokas, K. et al. Matrix metalloproteinase-21 is expressed epithelially during development and in cancer and is up-regulated by transforming growth factor-beta1 in keratinocytes. Lab. Invest. 83, 1887-1899 (2003).
48. Perles, Z. et al. A human laterality disorder caused by a homozygous deleterious mutation in MMP21. J. Med. Genet. 52, 840-847 (2015).
49. Liu, T., Zhang, L., Joo, D. & Sun, S.C. NF-kappaB signaling in inflammation. Signal Transduct Target Ther 2, 17023- (2017).
50. Caldwell, C.M., Green, R.A. & Kaplan, K.B. APC mutations lead to cytokinetic failures in vitro and tetraploid genotypes in Min mice. J. Cell Biol. 178, 1109-1120 (2007).
51. Fleming, E.S., Temchin, M., Wu, Q., Maggio-Price, L. & Tirnauer, J.S. Spindle misorientation in tumors from APC(min/+) mice. Mol. Carcinog. 48, 592-598 (2009).
52. Quyn, A.J. et al. Spindle orientation bias in gut epithelial stem cell compartments is lost in precancerous tissue. Cell Stem Cell 6, 175-181 (2010).
53. Aoki, K. & Taketo, M.M. Adenomatous polyposis coli (APC): a multi-functional tumor suppressor gene. J. Cell Sci. 120, 3327-3335 (2007).
54. McCartney, B.M. & Näthke, I.S. Cell regulation by the Apc protein Apc as master regulator of epithelia. Curr. Opin. Cell Biol. 20, 186-193 (2008).
55. Karin, M. & Greten, F.R. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol. 5, 749-759 (2005).
56. Nagase, H. & Woessner, J.F., Jr. Matrix metalloproteinases. J. Biol. Chem. 274, 21491-21494 (1999).
57. Page-McCaw, A., Ewald, A.J. & Werb, Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat. Rev. Mol. Cell Biol. 8, 221-233 (2007).
58. Quintero-Fabian, S. et al. Role of Matrix Metalloproteinases in Angiogenesis and Cancer. Front Oncol 9, 1370 (2019).
59. Zhang, J. et al. Overexpression of MMP21 and MMP28 is associated with gastric cancer progression and poor prognosis. Oncol Lett 15, 7776-7782 (2018).
60. Vogelstein, B. et al. Genetic alterations during colorectal-tumor development. N Engl J Med 319, 525-532 (1988).
61. Leslie, A., Carey, F.A., Pratt, N.R. & Steele, R.J. The colorectal adenoma-carcinoma sequence. Br J Surg 89, 845-860 (2002).
62. Tomasetti, C., Li, L. & Vogelstein, B. Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention. Science 355, 1330-1334 (2017).
63. Tomasetti, C. & Vogelstein, B. Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions. Science 347, 78-81 (2015).
64. Barker, N. et al. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457, 608-611 (2009).
65. Shih, I.M. et al. Top-down morphogenesis of colorectal tumors. Proc Natl Acad Sci U S A 98, 2640-2645 (2001).
66. Huels, D.J. & Sansom, O.J. Stem vs non-stem cell origin of colorectal cancer. Br. J. Cancer 113, 1-5 (2015).
67. Schwitalla, S. et al. Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties. Cell 152, 25-38 (2013).
68. Westphalen, C.B. et al. Long-lived intestinal tuft cells serve as colon cancer-initiating cells. J. Clin. Invest. 124, 1283-1295 (2014).
69. Machida, H. et al. Narrow-band imaging in the diagnosis of colorectal mucosal lesions: a pilot study. Endoscopy 36, 1094-1098 (2004).
70. Watanabe, H. et al. Mutant p53-Expressing Cells Undergo Necroptosis via Cell Competition with the Neighboring Normal Epithelial Cells. Cell Rep 23, 3721-3729 (2018).
71. Kohashi, K. et al. Sequential oncogenic mutations influence cell competition. Curr. Biol. 31, 3984-3995 e3985 (2021).
72. Kawamoto, S. et al. A novel reporter mouse strain that expresses enhanced green fluorescent protein upon Cre-mediated recombination. FEBS Lett. 470, 263-268 (2000).
73. Sato, T. et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 459, 262-265 (2009).
74. Hogan, C. et al. Characterization of the interface between normal and transformed epithelial cells. Nat. Cell Biol. 11, 460-467 (2009).
75. Kajita, M. et al. Filamin acts as a key regulator in epithelial defence against transformed cells. Nat Commun 5, 4428 (2014).
76. Bernier-Latmani, J. & Petrova, T.V. High-resolution 3D analysis of mouse small-intestinal stroma. Nat Protoc 11, 1617-1629 (2016).